Literature DB >> 32483855

Factors in B cell competition and immunodominance.

Robert K Abbott1,2, Shane Crotty1,2,3.   

Abstract

The majority of all vaccines work by inducing protective antibody responses. The mechanisms by which the B cells responsible for producing protective antibodies are elicited to respond are not well understood. Interclonal B cell competition to complex antigens, particularly in germinal centers, has emerged as an important hurdle in designing effective vaccines. This review will focus on recent advances in understanding the roles of B cell precursor frequency, B cell receptor affinity for antigen, antigen avidity, and other factors that can substantially alter the outcomes of B cell responses to complex antigens. Understanding the interdependence of these fundamental factors that affect B cell responses can inform current vaccine design efforts for pathogens with complex proteins as candidate immunogens such as HIV, influenza, and coronaviruses.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HIV; complex antigens; germinal center; immunodominance; immunoglobulin; vaccine

Mesh:

Substances:

Year:  2020        PMID: 32483855      PMCID: PMC7641103          DOI: 10.1111/imr.12861

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   10.983


  124 in total

1.  Cutting edge: long-term B cell memory in humans after smallpox vaccination.

Authors:  Shane Crotty; Phil Felgner; Huw Davies; John Glidewell; Luis Villarreal; Rafi Ahmed
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

2.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

3.  Visualizing antibody affinity maturation in germinal centers.

Authors:  Jeroen M J Tas; Luka Mesin; Giulia Pasqual; Sasha Targ; Johanne T Jacobsen; Yasuko M Mano; Casie S Chen; Jean-Claude Weill; Claude-Agnès Reynaud; Edward P Browne; Michael Meyer-Hermann; Gabriel D Victora
Journal:  Science       Date:  2016-02-18       Impact factor: 47.728

4.  HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.

Authors:  Joseph G Jardine; Daniel W Kulp; Colin Havenar-Daughton; Anita Sarkar; Bryan Briney; Devin Sok; Fabian Sesterhenn; June Ereño-Orbea; Oleksandr Kalyuzhniy; Isaiah Deresa; Xiaozhen Hu; Skye Spencer; Meaghan Jones; Erik Georgeson; Yumiko Adachi; Michael Kubitz; Allan C deCamp; Jean-Philippe Julien; Ian A Wilson; Dennis R Burton; Shane Crotty; William R Schief
Journal:  Science       Date:  2016-03-25       Impact factor: 47.728

5.  Anti-HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity.

Authors:  Pia Dosenovic; Ervin E Kara; Anna-Klara Pettersson; Andrew T McGuire; Matthew Gray; Harald Hartweger; Eddy S Thientosapol; Leonidas Stamatatos; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-16       Impact factor: 11.205

6.  CCR6 Defines Memory B Cell Precursors in Mouse and Human Germinal Centers, Revealing Light-Zone Location and Predominant Low Antigen Affinity.

Authors:  Dan Suan; Nike J Kräutler; Jesper L V Maag; Danyal Butt; Katherine Bourne; Jana R Hermes; Danielle T Avery; Clara Young; Aaron Statham; Michael Elliott; Marcel E Dinger; Antony Basten; Stuart G Tangye; Robert Brink
Journal:  Immunity       Date:  2017-12-19       Impact factor: 31.745

7.  Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.

Authors:  Joyce K Hu; Jordan C Crampton; Albert Cupo; Thomas Ketas; Marit J van Gils; Kwinten Sliepen; Steven W de Taeye; Devin Sok; Gabriel Ozorowski; Isaiah Deresa; Robyn Stanfield; Andrew B Ward; Dennis R Burton; Per Johan Klasse; Rogier W Sanders; John P Moore; Shane Crotty
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

Review 8.  When designing vaccines, consider the starting material: the human B cell repertoire.

Authors:  Colin Havenar-Daughton; Robert K Abbott; William R Schief; Shane Crotty
Journal:  Curr Opin Immunol       Date:  2018-09-03       Impact factor: 7.486

9.  Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens.

Authors:  Xiaodong Xiao; Weizao Chen; Yang Feng; Zhongyu Zhu; Ponraj Prabakaran; Yanping Wang; Mei-Yun Zhang; Nancy S Longo; Dimiter S Dimitrov
Journal:  Biochem Biophys Res Commun       Date:  2009-09-11       Impact factor: 3.575

10.  Role of nanoscale antigen organization on B-cell activation probed using DNA origami.

Authors:  Rémi Veneziano; Tyson J Moyer; Matthew B Stone; Eike-Christian Wamhoff; Benjamin J Read; Sayak Mukherjee; Tyson R Shepherd; Jayajit Das; William R Schief; Darrell J Irvine; Mark Bathe
Journal:  Nat Nanotechnol       Date:  2020-06-29       Impact factor: 40.523

View more
  28 in total

1.  Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus.

Authors:  Maya Sangesland; Alba Torrents de la Peña; Seyhan Boyoglu-Barnum; Larance Ronsard; Faez Amokrane Nait Mohamed; Thalia Bracamonte Moreno; Ralston M Barnes; Daniel Rohrer; Nils Lonberg; Musie Ghebremichael; Masaru Kanekiyo; Andrew Ward; Daniel Lingwood
Journal:  Immunity       Date:  2022-08-10       Impact factor: 43.474

Review 2.  Pediatric Kidney Transplantation-Can We Do Better? The Promise and Limitations of Epitope/Eplet Matching.

Authors:  Olga Charnaya; Daniella Levy Erez; Sandra Amaral; Dimitrios S Monos
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

3.  Non-Muscle Myosin II Is Essential for the Negative Regulation of B-Cell Receptor Signaling and B-Cell Activation.

Authors:  Margaret K Seeley-Fallen; Michelle Lazzaro; Chaohong Liu; Quan-Zhen Li; Arpita Upadhyaya; Wenxia Song
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

4.  Structural basis of a public antibody response to SARS-CoV-2.

Authors:  Meng Yuan; Hejun Liu; Nicholas C Wu; Chang-Chun D Lee; Xueyong Zhu; Fangzhu Zhao; Deli Huang; Wenli Yu; Yuanzi Hua; Henry Tien; Thomas F Rogers; Elise Landais; Devin Sok; Joseph G Jardine; Dennis R Burton; Ian A Wilson
Journal:  bioRxiv       Date:  2020-06-09

5.  B and Th cell response to Ag in vivo: Implications for vaccine development and diseases.

Authors:  Richard B Kennedy; Irina Grigorova
Journal:  Immunol Rev       Date:  2020-07       Impact factor: 10.983

Review 6.  Time to get ill: the intersection of viral infections, sex, and the X chromosome.

Authors:  Katherine S Forsyth; Montserrat C Anguera
Journal:  Curr Opin Physiol       Date:  2020-10-13

Review 7.  Codon Usage and Adenovirus Fitness: Implications for Vaccine Development.

Authors:  Judit Giménez-Roig; Estela Núñez-Manchón; Ramon Alemany; Eneko Villanueva; Cristina Fillat
Journal:  Front Microbiol       Date:  2021-02-10       Impact factor: 5.640

8.  B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients.

Authors:  Víctor A Sosa-Hernández; Jiram Torres-Ruíz; Rodrigo Cervantes-Díaz; Sandra Romero-Ramírez; José C Páez-Franco; David E Meza-Sánchez; Guillermo Juárez-Vega; Alfredo Pérez-Fragoso; Vianney Ortiz-Navarrete; Alfredo Ponce-de-León; Luis Llorente; Laura Berrón-Ruiz; Nancy R Mejía-Domínguez; Diana Gómez-Martín; José L Maravillas-Montero
Journal:  Front Immunol       Date:  2020-12-03       Impact factor: 7.561

9.  Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients.

Authors:  Yang Li; Ming-Liang Ma; Qing Lei; Feng Wang; Wei Hong; Dan-Yun Lai; Hongyan Hou; Zhao-Wei Xu; Bo Zhang; Hong Chen; Caizheng Yu; Jun-Biao Xue; Yun-Xiao Zheng; Xue-Ning Wang; He-Wei Jiang; Hai-Nan Zhang; Huan Qi; Shu-Juan Guo; Yandi Zhang; Xiaosong Lin; Zongjie Yao; Jiaoxiang Wu; Huiming Sheng; Yanan Zhang; Hongping Wei; Ziyong Sun; Xionglin Fan; Sheng-Ce Tao
Journal:  Cell Rep       Date:  2021-03-12       Impact factor: 9.423

Review 10.  Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines.

Authors:  Maya Sangesland; Daniel Lingwood
Journal:  Vaccines (Basel)       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.